why choose us

First received: February 16, 2025

Clinical Trial: Intravenous Nalbuphine for Prevention of Intrathecal Morphine-induced Nausea and Vomiting in Patients Undergoing Cesarean Section: A Double-blind, Randomized Controlled Trial.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Intrathecal Morphine

Study Type: INTERVENTIONAL


Official Title: Intravenous Nalbuphine for Prevention of Intrathecal Morphine-induced Nausea and Vomiting in Patients Undergoing Cesarean Section: A Double-blind, Randomized Controlled Trial.

Brief Summary: We study efficacy of iv nalbuphine in prevention of intrathecal morphine-induced nausea and vomiting in patients undergoing cesarean section.

Read more